FGFR2 Gene Translocation: Clinical Trials

1 trial for FGFR2 Gene Translocation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1

Follow FGFR2 Gene Translocation: new trials by email Literature Review of FGFR2 Gene Translocation trials Research Report on FGFR2 Gene Translocation

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pemigatinib for the Treatment of Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations
Pemigatinib, Quality-of-Life Assessment - FGFR1 Gene Amplification, FGFR1 Gene Mutation
Phase 2UnknownAcademic and Community Cancer Research United142020-08-312024-02-21

Narrower conditions

Colorectal Neoplasms (1)

Broader conditions

Colonic Diseases (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)  ·  Intestinal Diseases (1)  ·  Intestinal Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Rectal Diseases (1)

Interventions

pemigatinib (1)

Sponsors

Academic and Community Cancer Research United (1)

Countries

United States (1)

Top investigators

Kristen K Ciombor (1)

Results publications

PMID 40515475

NIH funding

P30CA015083 (1)